Lars joined NLC in July 2017 after finishing his master’s degree at the London School of Economics.
He is driven by the goal of making a positive societal impact through entrepreneurship. With the rest of the Venture Finance team, Lars is responsible for designing and validating the business models of NLC’s new healthtech ventures by managing financing rounds (both dilutive and non-dilutive) and developing novel financial propositions to ensure all NLC portfolio companies are financed according to need.
This is all done with a single goal in mind: to accelerate the growth of NLC’s venture portfolio and bring more groundbreaking medical innovations to the patient.